Suppression of proliferative defects associated with processing-defective lamin A mutants by hTERT or inactivation of p53.
暂无分享,去创建一个
[1] Richard T. Lee,et al. Increased mechanosensitivity and nuclear stiffness in Hutchinson–Gilford progeria cells: effects of farnesyltransferase inhibitors , 2008, Aging cell.
[2] Kaushik Sengupta,et al. Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. , 2008, Genes & development.
[3] T. Misteli,et al. Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing , 2008, Nature Cell Biology.
[4] P. Rabinovitch,et al. Accelerated telomere shortening and replicative senescence in human fibroblasts overexpressing mutant and wild-type lamin A. , 2008, Experimental cell research.
[5] Sandy S. Tungteakkhun,et al. Cellular binding partners of the human papillomavirus E6 protein , 2008, Archives of Virology.
[6] B. Kennedy,et al. Evidence that Proteasome-Dependent Degradation of the Retinoblastoma Protein in Cells Lacking A-Type Lamins Occurs Independently of Gankyrin and MDM2 , 2007, PloS one.
[7] N. Lévy,et al. An association of Hutchinson–Gilford progeria and malignancy , 2007, American journal of medical genetics. Part A.
[8] B. Kennedy,et al. Werner and Hutchinson–Gilford progeria syndromes: mechanistic basis of human progeroid diseases , 2007, Nature Reviews Molecular Cell Biology.
[9] G. Sluder,et al. p53-independent abrogation of a postmitotic checkpoint contributes to human papillomavirus E6-induced polyploidy. , 2007, Cancer research.
[10] R. Foisner,et al. Nucleoplasmic lamins and their interaction partners, LAP2α, Rb, and BAF, in transcriptional regulation , 2007, The FEBS journal.
[11] Richard T. Lee,et al. Lamins A and C but Not Lamin B1 Regulate Nuclear Mechanics* , 2006, Journal of Biological Chemistry.
[12] Y. Gruenbaum,et al. The nuclear lamina and its proposed roles in tumorigenesis: projection on the hematologic malignancies and future targeted therapy. , 2006, Journal of structural biology.
[13] M. Bergo,et al. A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation. , 2006, The Journal of clinical investigation.
[14] B. Kennedy,et al. Stabilization of the Retinoblastoma Protein by A-Type Nuclear Lamins Is Required for INK4A-Mediated Cell Cycle Arrest , 2006, Molecular and Cellular Biology.
[15] Tom Misteli,et al. Distinct structural and mechanical properties of the nuclear lamina in Hutchinson–Gilford progeria syndrome , 2006, Proceedings of the National Academy of Sciences.
[16] A. Klingelhutz,et al. Human Papillomavirus Type 16 E6 Activates NF-κB, Induces cIAP-2 Expression, and Protects against Apoptosis in a PDZ Binding Motif-Dependent Manner , 2006, Journal of Virology.
[17] T. Misteli,et al. Lamin A-Dependent Nuclear Defects in Human Aging , 2006, Science.
[18] Stephen G Young,et al. A Protein Farnesyltransferase Inhibitor Ameliorates Disease in a Mouse Model of Progeria , 2006, Science.
[19] Richard L. Frock,et al. Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation. , 2006, Genes & development.
[20] J. O'connor,et al. A mechanism of AP-1 suppression through interaction of c-Fos with lamin A/C. , 2006, Genes & development.
[21] M. W. Glynn,et al. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition. , 2005, Human molecular genetics.
[22] B. Kennedy,et al. HIV protease inhibitors block adipocyte differentiation independently of lamin A/C , 2005, AIDS.
[23] Joel H. Janes,et al. Correction of cellular phenotypes of Hutchinson-Gilford Progeria cells by RNA interference , 2005, Human Genetics.
[24] M. Gelb,et al. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[25] Ignacio Varela,et al. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation , 2005, Nature.
[26] Karen N Conneely,et al. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[27] M. Gelb,et al. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[28] E. Parry,et al. Molecular cytogenetic insights into the ageing syndrome Hutchinson-Gilford Progeria (HGPS) , 2005, Cytogenetic and Genome Research.
[29] M. Gelb,et al. Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[30] David J. Chen,et al. Genomic instability in laminopathy-based premature aging , 2005, Nature Medicine.
[31] Richard L. Frock,et al. A-type nuclear lamins, progerias and other degenerative disorders , 2005, Mechanisms of Ageing and Development.
[32] T. Misteli,et al. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome , 2005, Nature Medicine.
[33] E. Furth,et al. Telomere Shortening Exposes Functions for the Mouse Werner and Bloom Syndrome Genes , 2004, Molecular and Cellular Biology.
[34] R. DePinho,et al. Essential role of limiting telomeres in the pathogenesis of Werner syndrome , 2004, Nature Genetics.
[35] Richard L. Frock,et al. A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[36] R. Faragher,et al. Fibroblast clones from patients with Hutchinson–Gilford progeria can senesce despite the presence of telomerase , 2004, Experimental Gerontology.
[37] Richard T. Lee,et al. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. , 2004, The Journal of clinical investigation.
[38] Pierre Cau,et al. Lamin A Truncation in Hutchinson-Gilford Progeria , 2003, Science.
[39] L. Mounkes,et al. A progeroid syndrome in mice is caused by defects in A-type lamins , 2003, Nature.
[40] Laura Scott,et al. Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome , 2003, Nature.
[41] R. Hegele,et al. LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670) but not in Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090) , 2003, Journal of Human Genetics.
[42] Karl Münger,et al. Human papillomavirus immortalization and transformation functions. , 2002, Virus research.
[43] J. Campisi,et al. Reversible Manipulation of Telomerase Expression and Telomere Length , 2002, The Journal of Biological Chemistry.
[44] Sui Huang,et al. Alteration of nuclear lamin organization inhibits RNA polymerase II–dependent transcription , 2002, The Journal of cell biology.
[45] D. Galloway,et al. E Box-Dependent Activation of Telomerase by Human Papillomavirus Type 16 E6 Does Not Require Induction of c-myc , 2001, Journal of Virology.
[46] C. Woodworth,et al. Papillomavirus Type 16 Oncogenes Downregulate Expression of Interferon-Responsive Genes and Upregulate Proliferation-Associated and NF-κB-Responsive Genes in Cervical Keratinocytes , 2001, Journal of Virology.
[47] J. Shay,et al. The establishment of telomerase-immortalized cell lines representing human chromosome instability syndromes. , 2000, Human molecular genetics.
[48] R. Faragher,et al. Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts , 2000, Nature Genetics.
[49] R. Goldman,et al. Disruption of Nuclear Lamin Organization Alters the Distribution of Replication Factors and Inhibits DNA Synthesis , 1997, The Journal of cell biology.
[50] J. McDougall,et al. Telomerase activation by the E6 gene product of human papillomavirus type 16 , 1996, Nature.
[51] C Roskelley,et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[52] K. Ishizaki,et al. Mutation spectrum of the retinoblastoma gene in osteosarcomas. , 1994, Cancer research.
[53] A. Kupfer,et al. The processing pathway of prelamin A. , 1994, Journal of cell science.
[54] L. Wenger,et al. Nucleoplasmic localization of prelamin A: implications for prenylation-dependent lamin A assembly into the nuclear lamina. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[55] J. Shay,et al. A role for both RB and p53 in the regulation of human cellular senescence. , 1991, Experimental cell research.
[56] K. Weber,et al. Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study. , 1989, Development.
[57] M. Kirschner,et al. Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins , 1986, Nature.
[58] J. Campbell,et al. Osteosarcoma in a patient with Hutchinson-Gilford progeria. , 1978, Journal of medical genetics.